(Q38112325)

29 August 2017

title

The new metabolic treatments for sarcopenia (English)

1 reference

29 August 2017

1 reference

Christian Barillaro

1

1 reference

29 August 2017

Rosa Liperoti

2

1 reference

29 August 2017

Anna Maria Martone

3

1 reference

29 August 2017

Graziano Onder

4

1 reference

29 August 2017

Francesco Landi

5

1 reference

29 August 2017

publication date

4 April 2013

1 reference

Aging Clinical and Experimental Research

29 August 2017

published in

1 reference

29 August 2017

volume

25

1 reference

29 August 2017

issue

2

1 reference

29 August 2017

page(s)

119-127

1 reference

https://scigraph.springernature.com/pub.10.1007/s40520-013-0030-0

29 August 2017

exact match

0 references

cites work

Understanding sarcopenia as a geriatric syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Vitamin d deficiency/insufficiency practice patterns in a veterans health administration long-term care population: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Nutritional recommendations for the management of sarcopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Current and future pharmacologic treatment of sarcopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Vitamin D receptor genotype is associated with fat-free mass and sarcopenia in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity: studies in human skin fibroblasts bearing vitamin D receptor mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

A prospective study of the associations between 25-hydroxy-vitamin D, sarcopenia progression and physical activity in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Vitamin D and ageing: neurological issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Vitamin D and neurocognitive dysfunction: preventing "D"ecline?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Dietary protein recommendations and the prevention of sarcopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Increase in anterior tibialis muscle protein synthesis in healthy man during mixed amino acid infusion: studies of incorporation of [1-13C]leucine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Amino acid ingestion improves muscle protein synthesis in the young and elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by beta-hydroxy-beta-methylbutyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Effect of beta-hydroxy-beta-methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Citrulline/malate promotes aerobic energy production in human exercising muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Antioxidative defence alterations in skeletal muscle during prolonged acclimation to cold: role of L-arginine/NO-producing pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Ornithine alpha-ketoglutarate: could it be a new therapeutic option for sarcopenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Effect of estrogenic compounds (estrogen or phytoestrogens) combined with exercise on bone and muscle mass in older individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Effects of a soy protein diet on exercise-induced muscle protein catabolism in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-013-0030-0

10.1007/S40520-013-0030-0

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1045832494

0 references

1 reference